Unveiling the potential of marine-derived diterpenes from the order Alcyonacea as promising anti-obesity agents

Tammam, Mohamed A., Aly, Omnia, Pereira, Florbela, Mahdy, Aldoushy and El-Demerdash, Amr ORCID: https://orcid.org/0000-0001-6459-2955 (2024) Unveiling the potential of marine-derived diterpenes from the order Alcyonacea as promising anti-obesity agents. Current Research in Biotechnology, 7. ISSN 2590-2628

[thumbnail of Tammam_etal_2024_CRiB]
Preview
PDF (Tammam_etal_2024_CRiB) - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (11MB) | Preview

Abstract

Metabolic syndrome (MS) represents a global health challenge characterized by various metabolic disorders, including HOMA-IR (insulin resistance), obesity, dyslipidemia, and hypertension. In our pursuit of identifying natural alternatives for the development of effective and safe anti-obesity medications, we examined the potential of the methanolic extract of the Red Sea derived soft coral Sarcophyton glaucum, where serum levels of glucose, insulin, HOMA-IR, lipid profile, fetuin A and B, PTP1Β (Protein tyrosine phosphatase 1B), adropin and omentin were determined. Furthermore, the expression of the UCP1 (Uncoupling protein 1) and PPARGC1A (Peroxisome proliferator–activated receptor-g coactivator-1a) genes have been assessed, to evaluate the anti-obesity potential of S. glaucum organic extract. Our findings demonstrated a significant decrease in glucose, HOMA-IR, cholesterol, triglyceride, LDL-C, fetuin A and B, and PTP1Β levels, accompanied by a significant increase in insulin, HDL-C, adropin, omentin, UCP1, and PPARGC1A expression after treatment with the soft coral extract. These promising outcomes can be attributed to the remarkable ingredients present in the extract, which were further supported by histopathological findings. In addition, a virtual screening protocol including molecular docking (MDock) and Structure-Activity Relationships (SARs) of 27 marine diterpenes was also explored to identify potential PTP1Β inhibitors targeting simultaneously the catalytic site and allosteric site, as well as fetuin A modulators. Moreover, the six most promising predicted marine diterpenes (4, 8, 9, 10, 13 and 14) were investigated for their pharmacokinetic properties, druglike nature and medicinal chemistry friendliness using the SwissADME platform. Of these, four marine diterpenes (4, 8, 9, and 10) were predicted to exhibit the appropriate drug-like properties.

Item Type: Article
Uncontrolled Keywords: alcyonacea,anti-obesity,diterpenes,fetuin a,ptp1Β,sarcophyton glaucum,virtual screening,biotechnology,sdg 3 - good health and well-being,sdg 14 - life below water ,/dk/atira/pure/subjectarea/asjc/1300/1305
Faculty \ School: Faculty of Science > School of Pharmacy (former - to 2024)
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 02 Aug 2024 15:30
Last Modified: 01 Nov 2024 12:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/96117
DOI: 10.1016/j.crbiot.2024.100175

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item